Cover Image

Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule

Saved in:

Bibliographic Details
Main Author:	Michael Abrouk, BS (Author)
Format:	Book
Published:	Wolters Kluwer, 2016-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Considerations on biologic agents in psoriasis with the new pregnancy lactation labeling rule
by: Michael Abrouk, et al.
Published: (2017)

Understanding the new FDA pregnancy and lactation labeling rules
by: Collin M. Blattner, D.O
Published: (2016)

New changes in pregnancy and lactation labelling: Review of dermatologic drugs
by: Yun Pei Koh, MBBS, et al.
Published: (2019)

An overview of upcoming changes in pregnancy and lactation labeling information
by: Mosley JF II, et al.
Published: (2015)

Considerable variation among Iranian dermatologists in the knowledge and attitudes regarding the use of biologic agents to manage psoriasis,
by: Mina Almasi-Nasrabadi, MD, et al.
Published: (2019)

Consideration of hormonal changes for orthodontic treatment during pregnancy and lactation - a review
by: Yujie Zhao, et al.
Published: (2024)

Clinical evidence of therapy for genital psoriasis by biologic agents
by: Evgeny V. Sokolovskiy, et al.
Published: (2021)

Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability
by: Farahnik B, et al.
Published: (2016)

Mechanics rules cell biology
by: Wang James HC, et al.
Published: (2010)

Update on biologic safety for patients with psoriasis during pregnancy
by: Martina L. Porter, et al.
Published: (2017)

Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
by: Aimilios Lallas, et al.
Published: (2016)

Drugs during Pregnancy and Lactation: New Solutions to Serious Challenges
by: Gideon Koren, et al.
Published: (2012)

Advancements in the Study of Biologic Agents in Comorbidities of Psoriasis: A Literature Review
by: Wang Y, et al.
Published: (2023)

Knowledge and Practice of General Dentists and Dental Students about Treatment Considerations during Pregnancy and lactation in Yazd, Iran
by: Fahimeh Rashidi Maybodi, et al.
Published: (2022)

Bimekizumab: the new drug in the biologics armamentarium for psoriasis
by: Egídio Freitas, et al.
Published: (2021)

Considerations for lactation with Ehlers-Danlos syndrome: a narrative review
by: Jimi Francis, et al.
Published: (2022)

Assessing public interest in sunscreen safety during pregnancy and lactation
by: Sarah Shareef, BS, et al.
Published: (2022)

Should Mammography Be a Prerequisite Prior to Initiation of Biological Agents in Patients With Psoriasis?
by: Funda Tamer, et al.
Published: (2022)

The Safety Profile of Biological Agents in Patients with Psoriasis and HIV: A Systematic Review
by: Niyaz Mostafa, et al.
Published: (2023)

Biological therapy of psoriasis
by: Sivamani Raja, et al.
Published: (2010)

Biologics in the treatment of psoriasis and emerging new therapies in the pipeline
by: Levy LL, et al.
Published: (2012)

Comorbidity in Adult Psoriasis: Considerations for the Clinician
by: Daugaard C, et al.
Published: (2022)

Clinical considerations for the management of psoriasis in women
by: Alice B. Gottlieb, MD, PhD, et al.
Published: (2019)

Differential access to psoriasis biologic information in English and Spanish
by: Max Oscherwitz, BS, et al.
Published: (2024)

The role of bacteria in lactational mastitis and some considerations of the use of antibiotic treatment
by: Hall-Lord Marie, et al.
Published: (2008)

A review of the safety of cosmetic procedures during pregnancy and lactation
by: M.K. Trivedi, BS, BA, et al.
Published: (2017)

90Y-labeled antimony trisulfide colloid as promising therapeutic agent: Physicochemical characterization and biological evaluation
by: Janković Drina Lj, et al.
Published: (2014)

Off-label use of biological agents in the management of uveitis: experience from a pediatric rheumatology centre
by: Ramos Filipa, et al.
Published: (2011)

Itolizumab - A New Biologic for Management of Psoriasis and Psoriatic Arthritis
by: Ganesh Pai, et al.
Published: (2017)

Because Internet: Understanding the new rules of language (a review)
by: Michael Carrier
Published: (2019)

Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labeling
by: Dhananjay D. Marathe, et al.
Published: (2023)

Careful consideration when responding to new data: dolutegravir and pregnancy
by: C. Foster, et al.
Published: (2018)

IRON DEFICIENCY DURING PREGNANCY, PREGNANCY AND LACTATION IN RAT
by: M. Froozani
Published: (1984)

Herpes zoster in psoriasis patients undergoing treatment with biological agents: prevalence, impact, and management challenges
by: el Hayderi L, et al.
Published: (2016)

The effect of biological agents on antinuclear antibody status in patients with psoriasis: A single-center study
by: Ömer Kutlu, et al.
Published: (2020)

Two Cases of Immune Drift Phenomena Caused by Biologic Agents for Treating Psoriasis and Atopic Dermatitis
by: Ma X, et al.
Published: (2023)

Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic
by: Haulrig MB, et al.
Published: (2021)

Managing dermatophytoses in pregnancy, lactation, and children
by: Smitha S Prabhu, et al.
Published: (2017)

Weter consumption during pregnancy and lactation
by: Figueroa Damián Ricardo, et al.
Published: (2014)

Pregnancy and lactation-associated breast carcinomas
by: Mathew Mary, et al.
Published: (2010)